References
- Giangrande PL. Historical review: the history of blood transfusion. Br J Haematol 2000;110:758–67. doi: 10.1046/j.1365-2141.2000.02139.x
- Mandal A, Robertson S. History of blood transfusion. News Medical Life Sciences. February 26, 2019. Available from https://www.news-medical.net/health/History-of-Blood-Transfusion.aspx. Accessed 21 October 2021.
- Reid ME, Shine I. The discovery and significance of the blood groups. Cambridge, MA: SBB Books, 2012.
- Pierce SR, Reid ME. Bloody brilliant: a history of blood groups and blood groupers. Bethesda, MD: AABB, 2016.
- Blundell J. Experiments on the transfusion of blood by the syringe. Med Chir Trans 1818;9:56–92. doi: 10.1177/09595287180090p107
- Ottenberg R. Reminiscences of the history of blood transfusion. J Mt. Sinai Hosp NY 1937;4:264–71.
- Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific, 1998.
- Coombs RRA, Mourant AE, Race RR. Detection of weak and incomplete Rh agglutinins: a new test. Lancet 1945;2:15.
- Coombs RRA, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol 1945;26:255.
- Harmening DM. Modern blood banking and transfusion practices. 7th ed. Philadelphia, PA: F.A. Davis Company, 2019.
- Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21: 58–71.
- Cohn CS, Delaney M, Johnson ST, Katz LM. AABB technical manual. 20th ed. Bethesda, MD: AABB, 2020.
- Maral S, Bakanay SM, Akinci S, Yikilmaz AS, Comert P, Dilek I. The least incompatible crossmatch red blood cell transfusion by biological compatibility test. Glob J Transfus Med 2019;4: 154–7.
- Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.
- Schanfield MS, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571–6. doi: 10.1046/j.1537-2995.1981.21582040822.x
- Flegel WA. Pathogenesis and mechanisms of antibody-mediated hemolysis. Transfusion 2015;55:S47–58.
- Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92–100.
- Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004; 44:1273–81.
- Nance S, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.
- Maurer J, Nance S, Nickle P. Relationship of antibody reactivity strength to reactivity in the monocyte monolayer assay (MMA). Transfusion 2018;58:187.
- Hunt JS, Beck ML, Hardman JT, Tegtmeier GE, Bayer WL. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction. Am J Clin Pathol 1980;74:259–64. doi: 10.1093/ajcp/74.3.259
- AuBuchon JP, Brightman A, Anderson HJ, Kim B. An example of Anti-Yta demonstrating a change in its clinical significance. Vox Sang 1988;55:171–5.
- Nance S, Scandone P, Fassl L, et al. Monocyte monolayer assay (MMA) results are affected by transfusion of incompatible red cells (abstract). Transfusion 1997;37(Suppl):37S.
- Branch DR, Sandhu G, Raos M. Monocyte monolayer predictions of clinical outcome for serologically incompatible red blood cells is all about timing. Transfusion 2021;61: 2516–7.